Correlation Between Parkinson's Disease, Constipation, and Dysphagia

Prevalence and Significance

More than 80% of patients with Parkinson's disease develop dysphagia during the course of their disease, with swallowing problems sometimes arising early in the disease course 1, 2
Dysphagia prevalence based on subjective outcomes is around 35% but increases to 82% when objective measures of swallowing dysfunction are used, indicating many PD patients have silent or unrecognized dysphagia 2, 3
Constipation is the most frequent non-motor symptom and manifestation of gastrointestinal dysfunction in PD patients 4, 5
Both symptoms can significantly impact nutritional status, medication efficacy, and overall quality of life 6

Dysphagia results from neurodegeneration affecting the central swallowing network and related structures 7
Risk factors for dysphagia in PD include Hoehn and Yahr stage above III, weight loss, BMI below 20 kg/m², drooling/sialorrhea, and dementia 1, 2
Only 20-40% of PD patients are aware of their swallowing dysfunction, and less than 10% report dysphagia spontaneously 2
Silent aspiration is very common in PD patients with dysphagia 2, 3
Constipation primarily results from neurodegenerative processes involving the enteric nervous system 4, 5
Contributing factors include side effects of PD medications and reduced physical activity associated with motor impairment 4, 5
Defecatory dysfunction in PD may be due to both slow colonic transit and pelvic floor dyssynergia 4, 5

Dysphagia is associated with high risk for decreased food and fluid intake, aspiration pneumonia, and malnutrition 2, 3
Pneumonia is the most frequent cause of death in Parkinson's disease and is substantially related to dysphagia 2, 3
Both symptoms contribute to weight loss and malnutrition, which affects approximately 15% of community-dwelling PD patients 8, 6
Fear of aspiration, choking, and food modification requirements can significantly reduce quality of life 2

All PD patients with Hoehn & Yahr stage above II or with weight loss, low BMI, drooling, dementia, or signs of dysphagia should be screened for dysphagia during an ON-phase 1, 2
Screening tools include PD-specific questionnaires or water swallow tests measuring average volume per swallow 1, 2
Regular monitoring of body weight and nutritional status is recommended at least yearly and whenever clinical conditions change 8, 6

For constipation, PD patients can benefit from fermented milk containing probiotics and prebiotic fiber in addition to increased water and fiber intake 4, 5
A large RCT demonstrated that daily consumption of fermented milk with probiotics and prebiotic fiber for 4 weeks improved bowel movements, stool consistency, and reduced laxative use compared to placebo 4, 5
Dysphagia management requires specialized assessment and often involves modification of food textures and swallowing techniques 1, 2

Both symptoms can occur early in the disease course but typically worsen as the disease progresses 1, 2
Weight loss requires monitoring and intervention as it is associated with increased disease severity 8, 6
Regular screening for these symptoms is essential as many patients do not report them spontaneously 2, 3

A patient with Parkinson's disease presenting with crackles should be immediately evaluated for aspiration pneumonia and undergo instrumental dysphagia assessment with FEES or VFSS, as silent aspiration occurs in the majority of PD patients with dysphagia and pneumonia is the leading cause of death in this population 9, 10
Obtain chest radiograph immediately to confirm or exclude pneumonia, as crackles in a PD patient with dysphagia strongly suggest aspiration pneumonia 11
Assess for fever, tachypnea, respiratory distress, and confusion—noting that older patients may present atypically without fever 11

FEES is the preferred method over VFSS for PD patients as it requires minimal cooperation, involves no radiation, can be performed bedside, and can be used therapeutically 9, 10
All PD patients who screen positive for dysphagia, have pneumonia, or show rapid disease deterioration require instrumental assessment 9, 10
Silent penetration and aspiration cannot be reliably detected by clinical assessment alone 9, 10

For ICU-level severity without Pseudomonas risk: IV beta-lactam (cefotaxime or ceftriaxone) plus IV macrolide (azithromycin) or IV fluoroquinolone 11
Consider aspiration pneumonia is typically polymicrobial from contaminated oral secretions 12
Implement oral hygiene protocols to reduce bacterial load in oral secretions 12

Perform screening during medication "ON" phase for accurate assessment, as dopaminergic treatment may improve dysphagia in some patients 10
Postural changes (chin-down or head-turn maneuvers) alter swallowing biomechanics and reduce aspiration occurrence based on specific impairments identified 12
Texture modification using IDDSI standards may be considered, though evidence for clinical outcomes is limited 12

Feeding tubes do NOT reduce aspiration of contaminated oral secretions, the primary cause of aspiration pneumonia 12
Gastrostomy tubes may actually increase gastric reflux by reducing lower esophageal sphincter pressure 12
Consider only for nutritional support when oral intake inadequate, not for aspiration prevention 12

Never assume absence of aspiration based on lack of coughing—silent aspiration is the norm in PD 9, 10
Do not use standard water swallow tests designed for stroke patients, as they are non-predictive in PD 9, 10